Aditxt, Inc. Files 8-K for Other Events and Exhibits

Ticker: ADTX · Form: 8-K · Filed: Mar 28, 2025 · CIK: 1726711

Sentiment: neutral

Topics: 8-K, filing, exhibits

TL;DR

Aditxt filed an 8-K on 3/28 for events on 3/24, including financials/exhibits.

AI Summary

Aditxt, Inc. filed an 8-K on March 28, 2025, reporting an event that occurred on March 24, 2025. The filing pertains to financial statements and exhibits, and other events. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and its principal executive offices are located in Mountain View, California.

Why It Matters

This 8-K filing indicates that Aditxt, Inc. is disclosing important corporate events and financial information to the public, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — This filing is a routine 8-K for other events and exhibits, not indicating any immediate significant financial distress or major operational changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Aditxt, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' that occurred on or before March 24, 2025.

When was this 8-K report filed with the SEC?

This 8-K report was filed with the SEC on March 28, 2025.

What was Aditxt, Inc. previously known as?

Aditxt, Inc. was formerly known as Aditx Therapeutics, Inc.

In which state is Aditxt, Inc. incorporated?

Aditxt, Inc. is incorporated in Delaware.

Where are Aditxt, Inc.'s principal executive offices located?

Aditxt, Inc.'s principal executive offices are located at 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding Aditxt, Inc. (ADTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing